Source: http://feedproxy.google.com/~r/wsj/health/feed/~3/jibZtXY8Paw/
Sunday, April 3, 2011
Yale and Gilead Sciences Sign $40 Million Pact in Search for Cancer Drugs
Gilead Sciences and the Yale School of Medicine are joining forces in the latest collaboration between industry and academia to hunt for new drugs. Gilead, known mostly for its line of medicines for HIV/AIDS, will pay $40 million for a four-year effort that could be extended to 10 years and a total of $100 million [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment